MARKER THERAPEUTICS, INC. — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/48be8d02-aec8-4ef2-91ba-7b2968226e02/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $3.5M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-031274 |
| FY 2024 | $6.6M | 2024-01-01 – 2024-12-31 | evidence 0001410578-25-000549 |
| FY 2023 | $3.3M | 2023-01-01 – 2023-12-31 | evidence 0001410578-24-000297 |
| FY 2022 | $3.5M | 2022-01-01 – 2022-12-31 | evidence 0001410578-24-000297 |
| FY 2021 | $1.2M | 2021-01-01 – 2021-12-31 | evidence 0001410578-22-000418 |
| FY 2020 | $466.8k | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-033855 |
| FY 2019 | $213.2k | 2019-01-01 – 2019-12-31 | evidence 0001104659-21-033855 |
| FY 2018 | $206.0k | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-014350 |
| FY 2017 | $183.1k | 2017-01-01 – 2017-12-31 | evidence 0001144204-19-014350 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MARKER THERAPEUTICS, INC. — all facts · Net Income · Operating Income